ANVISA-2020-0005-V105
Major variation for application ANVISA-2020-0005. Major variation: Specification Change for Haemoferrin — critical change
Variation Number
ANVISA-2020-0005-V105
Type
Major
Application
Change
Status
Draft
Fee
€23,795
Submitted
2022-08-12
Approved
—
Description
Major variation: Specification Change for Haemoferrin — critical change